LifeArc announces £5 million drug repurposing programme for motor neuron disease
Filter by:
  • All
  • News Releases
  • Articles & blogs
  • Ventures Funding
    • 27 July 2020

    Stabilised SARS-CoV-2 Spike protein variants

    What the technology does The S protein variants of SARS-CoV-2 can be used as a reagent for…